Sign In
Buy SXT
$112.87
-0.490 (-0.432%)
At Close: Jun 03, 2026
Sensient Announces Conference Call
05:06pm, Friday, 17'th Oct 2025
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 third quarter results at 8:30 a.m. CDT on Friday, October 31, 2025. In
Heartland's 3 Tactical Q2 Moves: Trimming Risk, Harvesting Losses, And Raising Cash
11:05am, Monday, 11'th Aug 2025
We remain patient and opportunistic, raising cash to capitalize on future volatility and focusing on stocks meeting our 10 Principles of Value Investing™. We initiated a position in Applied Material
Sensient Technologies: Ingredients Play Is Riding The Tougher Food Regulation Trend
12:21pm, Monday, 28'th Jul 2025
Sensient Technologies has seen a sharp share price rally, driven by hopes for regulatory tailwinds and healthier food trends, despite modest operational improvements. Recent earnings and sales growth
Sensient Posts 22% Profit Gain in Q2
07:02pm, Friday, 25'th Jul 2025
Sensient Posts 22% Profit Gain in Q2
Sensient Technologies Corporation (SXT) Q2 2025 Earnings Call Transcript
02:20pm, Friday, 25'th Jul 2025
Sensient Technologies Corporation (NYSE:SXT ) Q2 2025 Earnings Conference Call July 25, 2025 9:30 AM ET Company Participants Paul Manning - Chairman, CEO, President & Member of Scientific Advisory Com
Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2025
06:55am, Friday, 25'th Jul 2025
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial re
Sensient Declares Dividend
04:45pm, Thursday, 24'th Jul 2025
MILWAUKEE--(BUSINESS WIRE)--The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The cash divi
Sensient Announces Conference Call
04:15pm, Friday, 11'th Jul 2025
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 second quarter results at 8:30 a.m. CDT on Friday, July 25, 2025. Inve
Top 2 Materials Stocks That May Fall Off A Cliff This Quarter
08:25am, Wednesday, 30'th Apr 2025
As of April 30, 2025, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Sensient Technologies Corporation (SXT) Q1 2025 Earnings Call Transcript
12:36pm, Friday, 25'th Apr 2025
Sensient Technologies Corporation (NYSE:SXT ) Q1 2025 Earnings Conference Call April 25, 2025 9:30 AM ET Company Participants Tobin Tornehl - Vice President and Chief Financial Officer Paul Manning -
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2025
06:55am, Friday, 25'th Apr 2025
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial re
Sensient Declares Dividend
06:37pm, Thursday, 24'th Apr 2025
MILWAUKEE--(BUSINESS WIRE)--The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The cash divi
Sensient Announces Conference Call
05:30pm, Friday, 11'th Apr 2025
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 first quarter results at 8:30 a.m. CDT on Friday, April 25, 2025. Inve
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency
08:30am, Monday, 17'th Mar 2025
TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”), a specialty pharmaceutical company focusing on the research, development, manuf
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
12:35pm, Friday, 21'st Feb 2025
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, develop
